Positive diagnostic values and histological detection ratios from the Rotterdam cervical cancer screening programme

International Journal of Epidemiology

Volumn 27, Issue 3, 1998, Pages 377-381

  Kreuger, Fré A F ^a   Beerman, Henk ^b   Nijs, Huub G T ^a,c   Van Ballegooijen, Marjolein ^c  

^a Public Health Service of the Rotterdam Region   (Netherlands)

^b Zuiderziekenhuis   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Cervical cancer screening; Histological detection ratio; Positive diagnostic value

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; COLPOSCOPY; DIAGNOSTIC VALUE; DYSPLASIA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; NORMAL HUMAN; PATIENT REFERRAL; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

ADULT; CARCINOMA IN SITU; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; PRECANCEROUS CONDITIONS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0031869169     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/27.3.377     Document Type: Article

References (15)

1. EVAC. Final Report of the Commission for the Evaluation of Screening for Cervical Carcinoma. (In Dutch.) Leyden: NIPG-TNO, 1988.
2. EVAC. Report on the Gynaecological Follow-up after the Screening Program for Cervical Cancer in the Experimental Areas Rotterdam and Nijmegen. (In Dutch.) Leyden: NIPG-TNO, 1991.
3. Van der Lee-Bijlsma A, Sloof R, Mulder PGH. Screening Programme for Cervical Cancer in the Experimental Area of Rotterdam, First, Second and Third Round (1976-1984). (In Dutch.) Rotterdam: GGD, 1988.
4. Kreuger FAF, Beerman H, Nijs HGT, Wijnen JA. Follow-up not according to guidelines after an abnormal cervix smear. (In Dutch.) Ned Tijdschr Geneeskd 1996;140:833-36.
5. Leyden Cytology and Pathology Laboratory. Annual Report 1991. (In Dutch.) Leyden: Coulomb Press, 1992.
6. Sickfund Council. Principles for Restructuring the National Screening Programme for Cervical Cancer. (In Dutch.) No. 592, 1993.
7. Oortmarssen GJ van, Habbema JDF. Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer. Br J Cancer 1991;64:559-65.
8. Kreuger FAF, Nijs HGT, Poel MBP van der. Determinants of attendance and cytological results for the national screening program for cervical cancer in the area of Rotterdam, 1989-1991. (In Dutch.) Tijdschr Soc Gezondheidsz 1994;72:309-13.
9. Ballegooijen M van, Habbema JDF, Oortmarssen GJ van et al. Preventive Pap-smears: balancing costs, risks and benefits. Br J Cancer 1992;65:930-33.
10. Boon ME, Rietveld WJ, Graaf Guilloud JC de. Increase of cervical carcinoma in situ in women under 35 years; analysis of data from general practice 1974-1986. (In Dutch.) Ned Tijdschr Geneekd 1988; 132:1240-43.
11. Gustafsson L, Sparén P, Gustafsson M et al. Low efficiency of cytologic screening for cancer in situ of the cervix in older women. Int J Cancer 1995;63:804-09.
12. Cecchini S, Ciatto S, Zappa M, Biggeri A. Trends in the prevalence of cervical intraepithelial neoplasia grade 3 in the district of Florence, Italy. Tumori 1995;81:303-33.
13. Beral V, Hermon C, Muñoz N, Devesa SS. Cervical cancer. Cancer Surv 1994; 19/20:265-85.
14. Balvert-Locht HR, Coebergh JWW, Brölmann HAM et al. Gynaecological malignancies in the south-east of The Netherlands. Trends in incidence and prognosis (1975-1988). (In Dutch.) Ned Tijdschr Obstet and Gynaecol 1991;104:170-6.
15. Ballegooijen M van, Boer R, Oortmarssen GJ van, Koopmanschap MA, Lubbe J Th N, Habbema JDF. Screening for Cervical Cancer: Age-limits and Intervals. An Actualised analysis on Cost-Effectiveness. (In Dutch.) Rotterdam: Department of Health Policy and Management, Erasmus University Rotterdam, 1993.